Panacea Life Sciences Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PLSH research report →
Companywww.panacealife.com
Panacea Life Sciences Holdings, Inc. , a seed to sale cannabinoid and nutraceutical manufacturer and research company, develops and produces natural pharmaceutical alternatives for consumers and pets. The company manufactures and sells softgels, gummies, tinctures, sublingual tablets, cosmetics, and other topicals.
- CEO
- Leslie A. Buttorff
- IPO
- 2022
- Employees
- 40
- HQ
- Greenwood Village, CO, US
Price Chart
Valuation
- Market Cap
- $615.49K
- P/E
- -0.43
- P/S
- 1.42
- P/B
- 0.32
- EV/EBITDA
- -0.63
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -341.24%
- Op Margin
- -325.37%
- Net Margin
- -916.75%
- ROE
- -350.61%
- ROIC
- -69.66%
Growth & Income
- Revenue
- $910.52K · -77.83%
- Net Income
- $-416,675 · 28.55%
- EPS
- $-0.01 · 77.85%
- Op Income
- $-1,753,336
- FCF YoY
- -10.36%
Performance & Tape
- 52W High
- $0.20
- 52W Low
- $0.02
- 50D MA
- $0.04
- 200D MA
- $0.05
- Beta
- 2.63
- Avg Volume
- 15.24K
Get TickerSpark's AI analysis on PLSH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 18, 23 | Buttorff Leslie | buy | 20,000 |
| Jun 9, 23 | Buttorff Leslie | buy | 3,000 |
| Jun 2, 23 | Buttorff Leslie | other | 760,000 |
| May 23, 23 | Buttorff Leslie | buy | 500 |
| May 19, 23 | Buttorff Leslie | buy | 1,500 |
| May 19, 23 | Buttorff Leslie | buy | 4,500 |
| May 9, 23 | Buttorff Leslie | buy | 2,300 |
| May 8, 23 | Buttorff Leslie | buy | 1,500 |
| May 5, 23 | Buttorff Leslie | buy | 11,500 |
| Apr 26, 23 | Buttorff Leslie | buy | 5,500 |
Our PLSH Coverage
We haven't published any research on PLSH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PLSH Report →